These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 30478149)
1. 3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism Modifiers. Jones DT; Valli A; Haider S; Zhang Q; Smethurst EA; Schug ZT; Peck B; Aboagye EO; Critchlow SE; Schulze A; Gottlieb E; Wakelam MJO; Harris AL Mol Cancer Ther; 2019 Feb; 18(2):376-388. PubMed ID: 30478149 [TBL] [Abstract][Full Text] [Related]
2. Simvastatin induced neurite outgrowth unveils role of cell surface cholesterol and acetyl CoA carboxylase in SH-SY5Y cells. Raina V; Gupta S; Yadav S; Surolia A PLoS One; 2013; 8(9):e74547. PubMed ID: 24040277 [TBL] [Abstract][Full Text] [Related]
3. PdpaMn inhibits fatty acid synthase-mediated glycolysis by down-regulating PI3K/Akt signaling pathway in breast cancer. Okrah EA; Wang Q; Fu H; Chen Q; Gao J Anticancer Drugs; 2020 Nov; 31(10):1046-1056. PubMed ID: 32649369 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models. Svensson RU; Parker SJ; Eichner LJ; Kolar MJ; Wallace M; Brun SN; Lombardo PS; Van Nostrand JL; Hutchins A; Vera L; Gerken L; Greenwood J; Bhat S; Harriman G; Westlin WF; Harwood HJ; Saghatelian A; Kapeller R; Metallo CM; Shaw RJ Nat Med; 2016 Oct; 22(10):1108-1119. PubMed ID: 27643638 [TBL] [Abstract][Full Text] [Related]
5. Up-regulation of acetyl-CoA carboxylase alpha and fatty acid synthase by human epidermal growth factor receptor 2 at the translational level in breast cancer cells. Yoon S; Lee MY; Park SW; Moon JS; Koh YK; Ahn YH; Park BW; Kim KS J Biol Chem; 2007 Sep; 282(36):26122-31. PubMed ID: 17631500 [TBL] [Abstract][Full Text] [Related]
6. Arsenic disulfide‑induced apoptosis and its potential mechanism in two‑ and three‑dimensionally cultured human breast cancer MCF‑7 cells. Zhao Y; Onda K; Yuan B; Tanaka S; Kiyomi A; Sugiyama K; Sugiura M; Takagi N; Hirano T Int J Oncol; 2018 Jun; 52(6):1959-1971. PubMed ID: 29620191 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of de novo Palmitate Synthesis by Fatty Acid Synthase Induces Apoptosis in Tumor Cells by Remodeling Cell Membranes, Inhibiting Signaling Pathways, and Reprogramming Gene Expression. Ventura R; Mordec K; Waszczuk J; Wang Z; Lai J; Fridlib M; Buckley D; Kemble G; Heuer TS EBioMedicine; 2015 Aug; 2(8):808-24. PubMed ID: 26425687 [TBL] [Abstract][Full Text] [Related]
8. Comparison of cancer cells in 2D vs 3D culture reveals differences in AKT-mTOR-S6K signaling and drug responses. Riedl A; Schlederer M; Pudelko K; Stadler M; Walter S; Unterleuthner D; Unger C; Kramer N; Hengstschläger M; Kenner L; Pfeiffer D; Krupitza G; Dolznig H J Cell Sci; 2017 Jan; 130(1):203-218. PubMed ID: 27663511 [TBL] [Abstract][Full Text] [Related]
9. Positive regulation of prostate cancer cell growth by lipid droplet forming and processing enzymes DGAT1 and ABHD5. Mitra R; Le TT; Gorjala P; Goodman OB BMC Cancer; 2017 Sep; 17(1):631. PubMed ID: 28877685 [TBL] [Abstract][Full Text] [Related]
10. Development of a Self-Assembled Nanoparticle Formulation of Orlistat, Nano-ORL, with Increased Cytotoxicity against Human Tumor Cell Lines. Hill TK; Davis AL; Wheeler FB; Kelkar SS; Freund EC; Lowther WT; Kridel SJ; Mohs AM Mol Pharm; 2016 Mar; 13(3):720-8. PubMed ID: 26824142 [TBL] [Abstract][Full Text] [Related]
11. Novel Strategy of Proxalutamide for the Treatment of Prostate Cancer through Coordinated Blockade of Lipogenesis and Androgen Receptor Axis. Gu Y; Xue M; Wang Q; Hong X; Wang X; Zhou F; Sun J; Wang G; Peng Y Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948018 [No Abstract] [Full Text] [Related]
12. Fasnall, a Selective FASN Inhibitor, Shows Potent Anti-tumor Activity in the MMTV-Neu Model of HER2(+) Breast Cancer. Alwarawrah Y; Hughes P; Loiselle D; Carlson DA; Darr DB; Jordan JL; Xiong J; Hunter LM; Dubois LG; Thompson JW; Kulkarni MM; Ratcliff AN; Kwiek JJ; Haystead TA Cell Chem Biol; 2016 Jun; 23(6):678-88. PubMed ID: 27265747 [TBL] [Abstract][Full Text] [Related]
13. FAK activity protects nucleostemin in facilitating breast cancer spheroid and tumor growth. Tancioni I; Miller NL; Uryu S; Lawson C; Jean C; Chen XL; Kleinschmidt EG; Schlaepfer DD Breast Cancer Res; 2015 Mar; 17():47. PubMed ID: 25880415 [TBL] [Abstract][Full Text] [Related]
14. Three-dimensional lung tumor microenvironment modulates therapeutic compound responsiveness in vitro--implication for drug development. Ekert JE; Johnson K; Strake B; Pardinas J; Jarantow S; Perkinson R; Colter DC PLoS One; 2014; 9(3):e92248. PubMed ID: 24638075 [TBL] [Abstract][Full Text] [Related]